Notably, increase of TCTP expression is commonly observed in various type of immune-refractory tumor cells to tumor antigen-vaccination, antigen-specific T cell ACT, and anti-PD-L1 therapy (Supplementary Fig. 19). The gene discussed is CD274; the disease is neoplasm.